Search Results 3391-3400 of 26264 for oral

  1. Portal Hypertension Clinical Trials - Mayo Clinic Research

    This is an Open Label, Multicenter, pilot clinical trial to assess the efficacy and safety of an oral selective Endothelin Receptor Antagonist (ambrisentan) in ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  4. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    * Oral corticosteroid (OCS; prednisone or equivalent) background therapy is permitted but not required. For participants taking OCS, the dose must be stable ...

  5. Spinal injury Archives - Mayo Clinic News Network

    Poor oral health has been debated as a possible cause of heart disease for many years. While there appears to be some connection between oral health and ...

  6. John L. Black, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral ExaminerPart II Exam, American Board of Psychiatry and Neurology. 1993 - present. Research MentorSection of General Psychiatry, Division of Adult ...

  7. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort - Mayo Clinic

    2h Post Glucose (PG) ≥ 200mg (11.1 mmol/L) during OGTT (oral glucose tolerance test); or. Any (1) PDM present followed by an anti-diabetes medication ...

  8. A Study of GIC-1001 for the Management of Visceral Pain During Sedation-Free, Full Colonoscopy - Mayo Clinic

    About this study. The purpose of this study is to assess the effectiveness and safety of GIC-1001, a new, orally-administered, colon analgesic drug, ...

  9. Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE) - Mayo Clinic

    Written or oral pediatric assent from the subject if deemed capable of ... Progestogen-only hormonal contraception associated with inhibition of ovulation, which ...

  10. Niacin Regulation of Regional Lipolysis - Mayo Clinic

    ... oral contraceptive medication, contraceptive device or abstinence while participating in the study. They will confirm use of one of these methods. * Recent ...